Known targets — ChEMBL curated mechanism
SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.91 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | PGD | P52209 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconic Acid SCHEMBL3411056 | 1.00 | PDE4A (0.91) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL6536096 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL1532403 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL4450093 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL4637030 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL207873 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL9735104 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL1066927 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL21224569 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL5706262 | 0.98 | PDE4A (0.95) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095470-A | Negative electrode, method for manufacturing the same, and all-solid-state battery including the same | — | 2026-05-26 | — | — | CN | claimed |
| CN-117990461-A | Glycosylated hemoglobin linear material and preparation method thereof | 精匠诊断技术(江苏)有限公司 | 2024-05-07 | — | — | CN | claimed |
| WO-2023215815-A1 | DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF | DABDOUB ATIF (US) | 2023-11-09 | — | — | WO | claimed |
| CN-110156493-B | Fair-faced concrete surface protective agent and preparation method thereof | 梁剑 | 2021-12-17 | — | — | CN | claimed |
| US-20200299563-A1 | METHODS OF CEMENTING A WELLBORE | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2020-09-24 | — | — | US | claimed |
| WO-2020190956-A1 | METHODS OF CEMENTING A WELLBORE | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2020-09-24 | — | — | WO | claimed |
| CN-110156493-A | A kind of faced concrete surface protective agent and preparation method thereof | 梁剑 | 2019-08-23 | — | — | CN | claimed |
| CN-122095470-A | Negative electrode, method for manufacturing the same, and all-solid-state battery including the same | — | 2026-05-26 | — | — | CN | disclosed |
| US-12629373-B2 | Dietary macro/micronutritional compositions and applications thereof | Dabdoub, Atif (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260083739-A1 | DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF | DABDOUB ATIF (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4430683-B1 | CARBON ANODE MATERIALS | FARADION LTD (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250057842-A1 | DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF | DABDOUB ATIF (US) | 2025-02-20 | — | — | US | disclosed |
| US-20240421305-A1 | CARBON ANODE MATERIALS | FARADION LIMITED (GB) | 2024-12-19 | — | — | US | disclosed |
| EP-2098219-A1 | Macrolide compositions having improved taste and stability | PARI Pharma GmbH (DE) | 2009-09-09 | — | — | EP | disclosed |
| US-20090035803-A1 | METHOD FOR STABILIZATION OF PEPTIDES IN A BIOLOGICAL SAMPLE | KYOWA MEDEX CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| WO-2008092939-A2 | PROCESS FOR THE PREPARATION OF OPTICALLY PURE OMEPRAZOLE VIA SALT FORMATION WITH A CHIRAL AMINE OR TREATMENT WITH AN ENTIOMER CONVERTING ENZYME AND CHROMATOGRAPHIC SEPARATION | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2008-08-07 | — | — | WO | disclosed |
| EP-1951868-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | Biomatrica, Inc. (US) | 2008-08-06 | — | — | EP | disclosed |
| CN-101228442-A | Method for stabilizing peptides in biological samples | KYOWA MEDEX CO LTD (JP) | 2008-07-23 | — | — | CN | disclosed |
| EP-1921453-A1 | METHOD OF STABILIZING PEPTIDE CONTAINED IN BIOSAMPLE | Kyowa Medex Co., Ltd. (JP) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007075253-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | BIOMATRICA, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629373-B2 | Dietary macro/micronutritional compositions and applications thereof | CPT1B, SLC39A3, SLC2A3 | PDE4A 1777/4885LMNA 1174/4885USP2 4374/4885 |
| US-20260083739-A1 | DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF | CPT1B, SLC39A3, SOD1 | PDE4A 1010/4885LMNA 1399/4885USP2 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.